Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma

ClinicalTrials.gov ID: NCT00101127

Public ClinicalTrials.gov record NCT00101127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation of Docetaxel (NSC #628503) and Gemcitabine (NSC #613327) Plus G-CSF in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus

Study identification

NCT ID
NCT00101127
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

  • filgrastim Biological
  • pegfilgrastim Biological
  • docetaxel Drug
  • gemcitabine hydrochloride Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2003
Primary completion
Jun 30, 2006
Completion
Not listed
Last update posted
Feb 13, 2014

Started 2003

United States locations

U.S. sites
60
U.S. states
25
U.S. cities
50
Facility City State ZIP Site status
Kaiser Permanente Medical Center - Los Angeles Los Angeles California 90027
Jonsson Comprehensive Cancer Center at UCLA Los Angeles California 90095-1781
Helen and Harry Gray Cancer Center at Hartford Hospital Hartford Connecticut 06102-5037
New Britain General Hospital New Britain Connecticut 06050
CCOP - Christiana Care Health Services Newark Delaware 19713
MBCCOP-Medical College of Georgia Cancer Center Augusta Georgia 30912
Medical Center of Central Georgia Macon Georgia 31208
Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia 31403-3089
Rush-Copley Cancer Care Center Aurora Illinois 60507
Rush University Medical Center Chicago Illinois 60612
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Hinsdale Hematology Oncology Associates Hinsdale Illinois 60521
Joliet Oncology-Hematology Associates, Limited - West Joliet Illinois 60435
Carle Cancer Center at Carle Foundation Hospital Urbana Illinois 61801
CCOP - Carle Cancer Center Urbana Illinois 61801
Saint Anthony Memorial Health Centers Michigan City Indiana 46360
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242
Woman's Hospital Baton Rouge Louisiana 70815
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231-2410
University of Mississippi Medical Center Jackson Mississippi 39216-4505
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203
CCOP - Kansas City Kansas City Missouri 64131
CCOP - Cancer Research for the Ozarks Springfield Missouri 65802
St. John's Regional Health Center Springfield Missouri 65804
Hulston Cancer Center at Cox Medical Center South Springfield Missouri 65807
Siteman Cancer Center at Barnes-Jewish Hospital St Louis Missouri 63110
Methodist Cancer Center at Methodist Hospital - Omaha Omaha Nebraska 68114
Fox Chase Virtua Health Cancer Program - Marlton Marlton New Jersey 08053
UMDNJ University Hospital Newark New Jersey 07103
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043
Fox Chase Virtua Health Cancer Program at Virtua West Jersey Voorhees Township New Jersey 08043
University of New Mexico Cancer Research and Treatment Center Albuquerque New Mexico 87131-5636
New York Oncology Hematology, PC at Albany Regional Cancer Care Albany New York 12208
SUNY Downstate Medical Center Brooklyn New York 11203
Stony Brook University Cancer Center Stony Brook New York 11794-8174
Hope A Women's Cancer Center Asheville North Carolina 28801
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295
Duke Comprehensive Cancer Center Durham North Carolina 27710
Forsyth Regional Cancer Center at Forsyth Medical Center Winston-Salem North Carolina 27103
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267
Case Comprehensive Cancer Center Cleveland Ohio 44106
Cleveland Clinic Cancer Center at Fairview Hospital Cleveland Ohio 44111
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Riverside Methodist Hospital Cancer Care Columbus Ohio 43214-3998
David L. Rike Cancer Center at Miami Valley Hospital Dayton Ohio 45409
Lake/University Ireland Cancer Center Mentor Ohio 44060
Oklahoma University Medical Center Oklahoma City Oklahoma 73104
Cancer Care Associates - Midtown Tulsa Tulsa Oklahoma 74104
Rosenfeld Cancer Center at Abington Memorial Hospital Abington Pennsylvania 19001
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850
Drexel University College of Medicine - Center City Hahnemann Campus Philadelphia Pennsylvania 19102
Fox Chase Cancer Center Philadelphia Pennsylvania 19111-2497
Women and Infants Hospital of Rhode Island Providence Rhode Island 02905
Hollings Cancer Center at Medical University of South Carolina Charleston South Carolina 29425
Rapid City Regional Hospital Rapid City South Dakota 57701
Avera Cancer Institute Sioux Falls South Dakota 57105
Baptist Centers for Cancer Care Memphis Tennessee 38120
University of Virginia Cancer Center Charlottesville Virginia 22908
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin 54601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00101127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 13, 2014 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00101127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →